BlaidsX Neuro vs Otofonix Groove

The BlaidsX Neuro is a mid-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. At $799 for this behind-the-ear, rechargeable device, it sits in a competitive price bracket where several higher-performing alternatives exist. In our testing, the Neuro shows a mixed performance profile. Its standout strength is speech clarity in quiet environments, scoring 3.3/5—a solid result that's 0.54 points above the OTC category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling or squealing during normal use. However, the device struggles in more challenging areas: speech in noise scores just 1.0/5 (0.48 points below category average), and music streaming registers at 0.0/5, significantly below the already-modest category average. Own-voice comfort is another weak point, scoring 1.7/5—well below the category average by 0.81 points. This may result in an unnatural sound of one's own voice during conversations. The tuned fit improves the overall score modestly from 3.3 to 3.5, primarily through enhanced feedback stability, though own-voice comfort decreases with the more occluding tulip dome coupling. The BlaidsX Neuro may suit users who primarily need help hearing speech in quieter settings and prioritize feedback-free performance. However, those who frequently encounter noisy environments, stream music, or have higher expectations for overall sound quality should consider alternatives in this price range, several of which score substantially higher in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.